Ascendis Pharma has been granted a patent for an auto injector designed to administer a medicament. The device includes features such as a cartridge receiver, drive module, and processing unit to ensure proper mixing of medicament components. An orientation sensor and onset signal further enhance functionality. GlobalData’s report on Ascendis Pharma gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Data Insights Ascendis Pharma AS - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on Ascendis Pharma, Nanoparticle drug conjugates was a key innovation area identified from patents. Ascendis Pharma's grant share as of May 2024 was 38%. Grant share is based on the ratio of number of grants to total number of patents.

Auto injector for administering medicament with mixing capabilities

Source: United States Patent and Trademark Office (USPTO). Credit: Ascendis Pharma AS

A newly granted patent (Publication Number: US11957880B2) discloses an auto injector designed for administering a medicament. The auto injector includes a housing, a cartridge receiver for receiving a cartridge containing two medicament components, an orientation sensor to detect the orientation of the cartridge and injector, a drive module to move a plunger rod for mixing the medicament components, and a processing unit to control the mixing process and provide an onset signal after a specified number of inversions. Importantly, the processing unit operates independently of the medicament's temperature, ensuring consistent performance.

Furthermore, the auto injector's orientation sensor, which may include accelerometers or gyroscopes, plays a crucial role in detecting the completion of inversions based on angular velocity and angle thresholds. The processing unit can provide feedback to the user through visible or acoustic signals, ensuring proper usage. Additionally, the injector can perform an air-shot after a set number of inversions, further enhancing its functionality. The patent also highlights the flexibility of defining inversion thresholds based on the auto injector or cartridge code features, allowing for customization based on specific requirements. Overall, this patented auto injector introduces innovative features to enhance the administration of medicaments, ensuring accurate mixing and reliable performance.

To know more about GlobalData’s detailed insights on Ascendis Pharma, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies